论文部分内容阅读
增殖性玻璃体视网膜病变 (Ｐｒｏｌｉｆｅｒａｔｉｖｅｖｉｔｒｅｏｒｅｔｉｎｏｐａｔｈｙ ,ＰＶＲ)是发生在玻璃体和视网膜严重的难治性致盲眼病 ,由于其确切病理机制仍不清楚 ,尽管手术技术的改善以及抗增生药的应用 ,但仍有高达 5 %～ 10 %的术后 (或治疗后 )病人再发ＰＶ?
Proliferative vitreoretinopathy (PVR) is a refractory and causative disease of the vitreous and retina. Due to its exact pathological mechanism remains unclear. Despite the improvement of surgical techniques and the application of anti-proliferative drugs, there are still up to 5% to 10% of postoperative (or post-treatment) patients with recurrent PV?